COVID-19 Advanced Care

Código QR

COVID-19 Advanced Care

The coronavirus disease 2019 (COVID-19) pandemic, related to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden and substantial burden in public health due to an enormous increase in hospitalizations for pneumonia with the multiorgan disease. Treatm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Evangelia Fouka, Ioannis Kalomenidis, Niki Gianniou, Sofia Gida, Paschalis Steiropoulos
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	SARS-CoV-2 severe acute respiratory syndrome antiviral agents systemic corticosteroids monoclonal antibodies passive immune therapies Medicine R
Acceso en línea:	https://doaj.org/article/cdea31a1e9344c23be48713865e7bb94
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021)

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect <italic toggle="yes">In Vivo</italic> in a Mouse Model in a Neutralization-Dependent Manner
por: Fatima Amanat, et al.
Publicado: (2021)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
por: Su-Jin Park, et al.
Publicado: (2020)

Antibody cocktail effective against variants of SARS-CoV-2
por: Kang-Hao Liang, et al.
Publicado: (2021)

Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years
por: Jia Li, et al.
Publicado: (2021)

New Clinical Anatomical Interpretation of COVID-19 Pandemic Infection
por: Al-Dorazi,Shorok, et al.
Publicado: (2021)

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
por: Maria L. Agostini, et al.
Publicado: (2018)

Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay
por: Alanoud Alshami, et al.
Publicado: (2021)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
por: Shin-ichiro Hattori, et al.
Publicado: (2020)

Surface‒Aerosol Stability and Pathogenicity of Diverse Middle East Respiratory Syndrome Coronavirus Strains, 2012‒2018
por: Neeltje van Doremalen, et al.
Publicado: (2021)

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
por: Daniel Gussarow, et al.
Publicado: (2021)

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
por: Helena Codina, et al.
Publicado: (2021)

SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021
por: Bode Shobayo, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Patrick K. Mitchell, et al.
Publicado: (2021)

Coronavirus Disease Contact Tracing Outcomes and Cost, Salt Lake County, Utah, USA, March–May 2020
por: Victoria L. Fields, et al.
Publicado: (2021)

COVID-19 Timeline of Vietnam: Important Milestones Through Four Waves of the Pandemic and Lesson Learned
por: Le Huu Nhat Minh, et al.
Publicado: (2021)

Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment
por: Nitin Goel, et al.
Publicado: (2021)

Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic—Results of the Pediatric Part of a Multicenter Polish Register SARSTer
por: Maria Pokorska-Śpiewak, et al.
Publicado: (2021)

MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants
por: Sua Lee, et al.
Publicado: (2021)

Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms
por: Damariz Marín-Palma, et al.
Publicado: (2021)

A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants
por: Paroma Deb, et al.
Publicado: (2021)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Shih-Chieh Shao, et al.
Publicado: (2021)

Real-Time Projections of SARS-CoV-2 B.1.1.7 Variant in a University Setting, Texas, USA
por: Kaitlyn E. Johnson, et al.
Publicado: (2021)

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May–August 2020
por: Maximilian Stich, et al.
Publicado: (2021)

SARS-CoV-2 Variants, South Sudan, January–March 2021
por: Daniel Lule Bugembe, et al.
Publicado: (2021)

Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy
por: Andreina Baj, et al.
Publicado: (2021)

Modern Epidemics: From the Spanish Flu to COVID-19
por: Megan A. Greischar
Publicado: (2021)

Antiviral Drug Discovery To Address the COVID-19 Pandemic
por: Douglas D. Richman
Publicado: (2020)

Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
por: Dorota Kamińska, et al.
Publicado: (2021)

Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
por: Dinesh Mohanraj, et al.
Publicado: (2021)

Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies
por: Brandon J. Beddingfield, et al.
Publicado: (2021)

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
por: Taweewun Hunsawong, et al.
Publicado: (2021)

A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue
por: Rama Devudu Puligedda, et al.
Publicado: (2021)

Assessment of COVID-19 Incidence and the Ability to Synthesise Anti-SARS-CoV-2 Antibodies of Paediatric Patients with Primary Immunodeficiency
por: Karolina Pieniawska-Śmiech, et al.
Publicado: (2021)

In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2
por: Minwoo Kim, et al.
Publicado: (2021)

Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Jamal Majidpoor, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
por: Jackie Kleynhans, et al.
Publicado: (2021)

Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion
por: Laurel Goldin, et al.
Publicado: (2021)

Detection of SARS-CoV-2 in Wastewater at Residential College, Maine, USA, August–November 2020
por: Yolanda M. Brooks, et al.
Publicado: (2021)

COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?
por: Abiu Sempere, et al.
Publicado: (2021)